Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Wright Reports
|
$472.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: GlobalData
|
$125.00
|
|
Provider: Datamonitor
|
$125.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Ipsen SA Opens Its New Commercial Headquarters in New Jersey (NJ)
Ipsen SA announced that it has opened its new commercial headquarters in Basking Ridge, New Jersey, the United States of America. The Company also announced that the growing pharmaceutical and biopharmaceutical industries were factors in Ipsen SA’ s decision to establish its United States headquarters in NJ.
Latest Developments for Ipsen SA
- Ipsen SA expects Increlex supply interruption due to supplier manufacturing issues
- Ipsen SA's Dysport Receives Approval in Canada; Dysport to Be Marketed in Canada by Medicis Aesthetics Canada
- Ipsen SA and Inspiration Biopharmaceuticals Inc Announce Closing of the IB1001 Sale to Cangene Corp
- Ipsen SA Announces Successful Completion of European Decentralised Registration Procedure for Eziclen/Izinova
Latest Key Developments in Pharmaceuticals
- AmerisourceBergen Corp Reaffirms FY 2013 EPS Gudiance-Conference Call
- Immunotec Inc Announces New CEO
- Novo Nordisk A/S Reports Positive Results from First Phase 3 Trial with Long-Acting Factor IX for Treatment of Haemophilia B
- Sanofi SA Announces Positive Results on Pivotal Study of Inhibitor in Myelofibrosis-DJ
- Share this
- Link this
- Digg this
Follow Reuters